Viroclinics-DDL and ENPICOM have announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application.

BioStrata has appointed four new team members to meet growing demand and the changing requirements of clients within life sciences.

PhoreMost Ltd., has announced it has completed an oversubscribed £33m ($46m) Series B investment round. The round was led by BGF, the UK’s most active growth economy investor, and included new investors XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures. Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.

Albumedix Ltd have announced that they have entered into a distribution agreement with FUJIFILM Wako in Japan and China including Hong Kong. The partnership further strengthens Albumedix’ commitment to advanced therapy and biopharmaceutical developers in the region.

Eppendorf continues to follow the path of sustainability by re-designing the CryoCube F570 (all voltages). The well-known standard-sized ultra-low temperature (ULT) freezer is now completely equipped with future-proof green cooling liquids and green insulation foam as well as better performance.

SignalChem Lifesciences announces a collaboration with Merck to evaluate the combination of SLC-391, a selective AXL inhibitor, with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).

SGD Pharma has introduced an industry-first offering of Type I molded glass vials. These market-driven value propositions represent the latest step in SGD Pharma’s ongoing improvements to its product offers and services.

IONTAS and FairJourney Biologics have announced the identification of neutralizing antibodies, which bind to multiple emerging SARS-CoV-2 variants. This identification has allowed for the development of a panel of therapeutic candidates.

Waters Corporation has introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists to monitor efficacy and safety through the analysis of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs.

Thermo Fisher Scientific has further expanded its Thermo Scientific General Purpose Pro Centrifuge Series with the addition of two new models designed to meet the needs of biopharmaceutical, cell and gene therapy, and academic research laboratories, as well as clinical diagnostic facilities, for enhanced sample safety and reproducibility, improved ergonomics and reduced noise levels.